
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 14, 2025, titled "Press Release and Management Discussion & Analysis of the Company for the Third Quarter ended December 31, 2024.".
Filed with NSE ·

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 14, 2025, titled "Press Release and Management Discussion & Analysis of the Company for the Third Quarter ended December 31, 2024.".
6ix hasn’t read this filing yet.
Glenmark Pharmaceuticals Limited on 6ix
Follow Glenmark Pharmaceuticals into a list and get an email when it puts out news.
Follow Glenmark Pharmaceuticals